Prevention of varicella-zoster virus infection in early childhood children: effect of 1 versus 2 doses of varicella vaccine on antibody levels
Infection · 2025
DOI: 10.1007/s15010-025-02532-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, 2025. Verfasst von Dan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changzhou Center for Disease Control and Prevention, Changzhou, China. Hauptthemen laut MEDLINE: Chickenpox Vaccine, Antibodies, Viral, Herpesvirus 3, Human, Chickenpox. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Open Research Fund Program of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University, Changzhou Medical young talent scienceand technology project, Changzhou Science and Technology Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVE: This study aimed to ascertain the factors influencing the varicella-zoster virus (VZV) IgG seropositivity and to evaluate the efficacy of varicella vaccination with 1- and 2-dose schedules. METHODS: A systematic sampling method was employed to recruit subjects. VZV IgG was calculated using the geometric mean concentration (GMC) and a 95% confidence interval (CI). A multifactorial logistic regression model was employed to calculate the odds ratios (OR) and to identify the influential factors for varicella antibody positivity. A generalized additive model for location, shape and scale (GAMLSS) was employed to compare centile reference values and centile curves of antibody levels for different doses of varicella vaccine (VarV). RESULTS: 785 individuals were included. The VarV positivity rate was 57.7% for 1 dose and 84.2% for 2 doses. Varicella antibody positivity was significantly associated with VarV doses and time since last vaccination. The GAMLSS model indicated a decline in VZV IgG over time, with the 2-dose group demonstrating superior performance to the 1-dose group across all centile reference values and curves. CONCLUSION: A 2-dose schedule is more effective in improving both VZV IgG seropositivity and GMC than a single dose. The inclusion of the VarV in routine immunization programme should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changzhou Center for Disease Control and Prevention, Changzhou, China.
- Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University, Nanjing, China.
- Center for Disease Control and Prevention, Zhonglou District, 99 Chahua Road, Changzhou, 213016, China. xqw168@126.com.
Förderung
- Open Research Fund Program of Changzhou Institute for Advanced Study of Public Health, Nanjing Medical University
- Changzhou Medical young talent scienceand technology project
- Changzhou Science and Technology Foundation
Zitieren
APA
Wu, D., Han, C., Xiong, S., Zhang, P., Gao, H., Jiang, J., Wang, F., Lv, X., Yao, F., & Xu, Q. (2025). Prevention of varicella-zoster virus infection in early childhood children: effect of 1 versus 2 doses of varicella vaccine on antibody levels. Infection. https://doi.org/10.1007/s15010-025-02532-w
Vancouver
Wu D, Han C, Xiong S, Zhang P, Gao H, Jiang J, et al. Prevention of varicella-zoster virus infection in early childhood children: effect of 1 versus 2 doses of varicella vaccine on antibody levels. Infection. 2025. doi:10.1007/s15010-025-02532-w
BibTeX
@article{Wu2025,
author = {Wu, Dan and Han, Changlei and Xiong, Suting and Zhang, Peipei and Gao, Han and Jiang, Jingyi and Wang, Fengming and Lv, Xufeng and Yao, Fang and Xu, Qinwen},
title = {Prevention of varicella-zoster virus infection in early childhood children: effect of 1 versus 2 doses of varicella vaccine on antibody levels},
journal = {Infection},
year = {2025},
doi = {10.1007/s15010-025-02532-w}
}
EUVIMED